The clinical performance is complex and often involves multi-systematic fatigue. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine diseases have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of IBD co-intestinal enlargement. The platform serves a team of internationally authoritative experts in the field of respiratory digestive endocrine in China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.